Adherencia y seguridad de la vigilancia activa en tumores de testículo

Rico, Luis; Blas, Leandro; Vitagliano, Gonzalo; Villasante, Nicolas; Rios Pita, Hernando; Contreras, Pablo; Lopez, Francisco Miguel; Ameri, Carlos.
Arch. esp. urol. (Ed. impr.) ; 74(4): 397-403, May 28, 2021. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-218210

Documentos relacionados

  1. [Active surveillance for testicular tumors: adherence and safety.]
  2. Stage I testicular seminoma risk-adapted therapeutic management.
  3. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.
  4. [Onset of Testicular Plasmacytoma in a Patient with Refractory Multiple Myeloma].
  5. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
  6. Surveillance versus Adjuvant Treatment with Chemotherapy or Radiotherapy for Stage I Seminoma: A Systematic Review and Meta-Analysis According to EAU COVID-19 Recommendations.
  7. Extrinsic apoptosis and senescence involved in growth kinetics of seminoma to cisplatin.
  8. High-intensity interval training and thromboembolic events during chemotherapy for testicular cancer: a retrospective analysis from the <i>Body & Cancer</i> cohort.
  9. Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective.
  10. The role of primary retroperitoneal lymph node dissection in the treatment of stage II seminoma.